Using the gene editing technology CRISPR, scientists have shed light on a rare, sometimes fatal syndrome that causes children to gradually lose the ability to manufacture vital blood cells. The research suggests new lines of investigation into how to treat this condition — dyskeratosis congenita — which is characterized by shortened telomeres. Short telomeres lead to progressive DNA damage that accumulates over time.
About The Author
4 April, 2018
16 August, 2017
Our Facebook Page
Facebook By Weblizar Powered By Weblizar
amniotic stem cells Biology Biotech california stem cells California Stem Cell Treatment Center Cancer Cell Surgical Network CIRM CRISPR Daily Daily News fat stem cells fda FDA stem cells Health iPS cells Jeanne Loring Kristin Comella Leigh Turner Medical research Pharma Research review Science Society Startups stem cell clinic stem cell clinical trials stem cell clinics stem cell law stem cell lawsuit Stem Cell News Stem Cell Research Stem cells Stem Cell Therapy stem cell treatment stem cell treatment cost Stemgenex SYN The Nutshell Top Story Uncategorized USRM Viacyte World news